![Anabella Villalobos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 50 100 $ al 30/09/2026
Dr. Anabella Villalobos is an Independent Director at Coya Therapeutics, Inc. She is on the Board of Directors at Coya Therapeutics, Inc. Dr. Villalobos was previously employed as a SVP-Biotherapeutics & Medicinal Sciences by Biogen, Inc. and a Vice President by Pfizer Inc. She received her undergraduate degree from the University of Panama and a doctorate degree from the University of Kansas.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
COYA THERAPEUTICS, INC. 0,04 % | 01/05/2026 | 10.000 ( 0,04 % ) | 50 100 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| COYA THERAPEUTICS, INC. | Director/Miembro de la Junta | 25/05/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2025 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Panama
 University of Panama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
